Objectives To test the hypothesis that observation with early salvage radiotherapy (SRT) is
not inferior to 'standard'treatment with adjuvant RT (ART) with respect to biochemical failure
in patients with pT3 disease and/or positive surgical margins (SMs) after radical
prostatectomy (RP). To compare the following secondary endpoints between the two arms:
patient‐reported outcomes, adverse events, biochemical failure‐free survival, overall
survival, disease‐specific survival, time to distant failure, time to local failure, cost utility …

… Re: A phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk
features: background and rationale of the Radiotherapy-Adjuvant versus Early Salvage (RAVES)
trial … Prostatic Neoplasms / radiotherapy* Radiotherapy, Adjuvant* …